Rakuten Securities’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5
Closed -$2.4K 968
2026
Q1
$2.4K Buy
5
+3
+150% +$1.54K ﹤0.01% 593
2025
Q4
$1.12K Buy
+2
New +$1.14K ﹤0.01% 681
2025
Q3
Sell
-7
Closed -$2.2K 932
2025
Q2
$2.2K Buy
7
+1
+17% +$300 ﹤0.01% 590
2025
Q1
$1.83K Buy
6
+1
+20% +$336 ﹤0.01% 602
2024
Q4
$1.66K Buy
5
+2
+67% +$678 ﹤0.01% 581
2024
Q3
$1K Sell
3
-49
-94% -$18.6K ﹤0.01% 576
2024
Q2
$21.4K Buy
52
+49
+1,633% +$19.4K 0.01% 248
2024
Q1
$1.21K Buy
3
+2
+200% +$703 ﹤0.01% 550
2023
Q4
$307 Buy
+1
New +$270 ﹤0.01% 540

Other funds holding MEDP

Rakuten Securities's MEDP Position: Q2 2026 in Review

Rakuten Securities sold out of Medpace (MEDP) in Q2 2026, closing a stake of 5 shares — an estimated $2.4K sold.

Rakuten Securities first reported a position in MEDP in Q4 2023 and held it in 9 quarters. The position peaked at $21.4K in Q2 2024. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Rakuten Securities reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Rakuten Securities sold 5 Medpace shares in Q2 2026, an estimated $2.4K.
  • Rakuten Securities first reported a position in Medpace in Q4 2023 and held it in 9 quarters.
  • Rakuten Securities's Medpace position peaked at $21.4K in Q2 2024.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.